Louis DN - Search Results

1

Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.

Cahill DP, Levine KK, Betensky RA, Codd PJ, Romany CA, Reavie LB, Batchelor TT, Futreal PA, Stratton MR, Curry WT, Iafrate AJ, Louis DN. Cahill DP, et al. Among authors: louis dn. Clin Cancer Res. 2007 Apr 1;13(7):2038-45. doi: 10.1158/1078-0432.CCR-06-2149. Clin Cancer Res. 2007. PMID: 17404084 Free PMC article.

2

p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.

von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR. von Deimling A, et al. Among authors: louis dn. Cancer Res. 1992 May 15;52(10):2987-90. Cancer Res. 1992. PMID: 1349850

3

Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.

von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR. von Deimling A, et al. Among authors: louis dn. Cancer Res. 1992 Aug 1;52(15):4277-9. Cancer Res. 1992. PMID: 1353411

4

The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC.

Rubio MP, Correa KM, Ueki K, Mohrenweiser HW, Gusella JF, von Deimling A, Louis DN. Rubio MP, et al. Among authors: louis dn. Cancer Res. 1994 Sep 1;54(17):4760-3. Cancer Res. 1994. PMID: 8062276

5

Accumulation of wild type p53 protein in human astrocytomas.

Rubio MP, von Deimling A, Yandell DW, Wiestler OD, Gusella JF, Louis DN. Rubio MP, et al. Among authors: louis dn. Cancer Res. 1993 Aug 1;53(15):3465-7. Cancer Res. 1993. PMID: 8339248

6

CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.

Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. Ueki K, et al. Among authors: louis dn. Cancer Res. 1996 Jan 1;56(1):150-3. Cancer Res. 1996. PMID: 8548755

7

Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.

Cheng LL, Chang IW, Louis DN, Gonzalez RG. Cheng LL, et al. Among authors: louis dn. Cancer Res. 1998 May 1;58(9):1825-32. Cancer Res. 1998. PMID: 9581820

8

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN. Ino Y, et al. Among authors: louis dn. Clin Cancer Res. 2001 Apr;7(4):839-45. Clin Cancer Res. 2001. PMID: 11309331

9

PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.

Sasaki H, Zlatescu MC, Betensky RA, Ino Y, Cairncross JG, Louis DN. Sasaki H, et al. Among authors: louis dn. Am J Pathol. 2001 Jul;159(1):359-67. doi: 10.1016/S0002-9440(10)61702-6. Am J Pathol. 2001. PMID: 11438483 Free PMC article.

10

Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.

Zlatescu MC, TehraniYazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN, Cairncross JG. Zlatescu MC, et al. Among authors: louis dn. Cancer Res. 2001 Sep 15;61(18):6713-5. Cancer Res. 2001. PMID: 11559541

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters